Viewing Study NCT02471820


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-01-17 @ 3:33 AM
Study NCT ID: NCT02471820
Status: COMPLETED
Last Update Posted: 2016-10-17
First Post: 2015-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
Sponsor: Meletios A. Dimopoulos
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RV-MM-GMSG-392
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators